HomeORGANIZATION
ORGANIZATION

JMA’s Nakagawa Pushes Price Cuts Even on Non-100 Billion Yen Products, Eyes Other Hep C Drugs
(Jan.18.2017)

JMA Vice President Toshio Nakagawa
Toshio Nakagawa, vice president of the Japan Medical Association (JMA), is calling for revising the so-called “huge-seller” re-pricing rule introduced last year, setting his sights on hepatitis C drugs similar to Harvoni (ledipasvir + sofosbuvir) and Sovaldi (sofosbuvir) ...
(LOG IN FOR FULL STORY)

News Calendar